Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Keeping Up With Market Trends


jerrio78
4 stars

152812 Reads | 154 Comments | 17 People call this a favourite

Looking at active issues and news to make the right move when investing.


  • Invictus MD releases new product for growers


    38 Reads | 0 Comments | 11 hours ago

      Invictus MD releases new product for growers 2015-04-20 08:44 ET - News Release   Mr. Dan Kriznic reports FUTURE HARVEST DEVELOPMENT RELEASES NEW PRODUCT: THE NUTRADIP GROWBOSS   Invictus MD Strategies Corp. vertical Future Harvest Development Ltd. is launching its newest Nutradip product, the GrowBoss. The GrowBoss will be available through leading distributors...


  • Could this drug be worth billions?


    268 Reads | 0 Comments | 2 days ago

    A $10,000 investment when this stock was at 4 cents would be over $55,000 today and then stock seems poised to keep climbing. GOING LONG ON HEALTH CARE STOCKS     Over the past several years I have bought into every sector after forensically going over the company's business plan and financials and along the road I won and lost. The funny thing is I can only remember one...


  • Antibe testing confirms ATB-346 efficacy at lower doses


    86 Reads | 0 Comments | 3 days ago

      Antibe testing confirms ATB-346 efficacy at lower doses 2015-04-17 07:50 ET - News Release   Mr. Dan Legault reports ANTIBE THERAPEUTICS ANNOUNCES ADDITIONAL VALIDATION DATA ON ATB-346 Antibe Therapeutics Inc. released today the results of additional testing of the in vivo activity of its lead anti-inflammatory drug, ATB-346. The results support the company's...


  • Volume alert!!


    91 Reads | 0 Comments | 4 days ago

    Volume alert!!  Invictus MD Strategies Corp(IMH:Canadian Securities Exchange, CA) 0.175 CAD Increase 0.005(2.94%) Volume 568,449


  • Could ATB-346 Turn Into A Billion Dollar Baby?


    63 Reads | 0 Comments | 5 days ago

    GOING LONG ON HEALTH CARE STOCKS     Over the past several years I have bought into every sector after forensically going over the company's business plan and financials and along the road I won and lost. The funny thing is I can only remember one story that I lost money on in the health care space and even that company is now up 3000%.   I wrote down every name...


  • Poydras Gaming arranges $11.5-million equity financing


    62 Reads | 0 Comments | 6 days ago

    Poydras Gaming arranges $11.5-million equity financing 2015-04-14 10:02 ET - News Release   Mr. Peter Macy reports POYDRAS GAMING FINANCE CORP. ANNOUNCES CAD $11.5MM EQUITY FINANCING Poydras Gaming Finance Corp. has entered into an equity financing, whereby Poydras will raise up to $11.5-million through a combination of private placement financing and short-form prospectus...


  • Antibe closes placement


    102 Reads | 0 Comments | 10 days ago

      Antibe closes $464,000 second tranche of placement 2015-04-10 00:57 ET - News Release   Mr. Dan Legault reports ANTIBE THERAPEUTICS COMPLETES FINAL CLOSING OF NON-BROKERED PRIVATE PLACEMENT BRINGING TOTAL PROCEEDS TO $1,250,000 Antibe Therapeutics Inc. has closed the second and final closing of its previously announced non-brokered private placement of units, raising...


  • Mezzi Holdings creates MLine cases division


    84 Reads | 0 Comments | 11 days ago

      Mezzi Holdings creates MLine cases division 2015-04-09 09:32 ET - News Release   Mr. Keir Reynolds reports     Mezzi Holdings Inc. is launching a new, wholly owned division called MLine cases. After streamlining its previous business, and due to the continued significant demand for the products that Mezzi Canada Inc. used to produce and retail prior to...